SCHEMBL19953971

SCHEMBL19953971

Cc1cc(C(C)(C)C)n(C2CCN(CCO)CC2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV4 Q9HBA0 1/20 0.41
DRD2 P14416 2/20 0.41
DRD4 P21917 1/20 0.41
DRD3 P35462 1/20 0.41
ALDH1A1 P00352 4/20 0.38
HPGD P15428 3/20 0.38
LMNA P02545 2/20 0.38
POLB P06746 1/20 0.38
GAA P10253 1/20 0.38
THRB P10828 1/20 0.38
TSHR P16473 1/20 0.38
SLC18A3 Q16572 1/20 0.36
NR3C1 P04150 1/20 0.36
ALOX15 P16050 2/20 0.36
ALOX12 P18054 1/20 0.36
HSD17B10 Q99714 1/20 0.36
APOBEC3G Q9HC16 1/20 0.36
PDE7A Q13946 1/20 0.33
KCNH2 Q12809 2/20 0.33
PIK3CA P42336 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25745827 0.88 DRD2 (0.41) DRD2DRD4DRD3ALDH1A1HTR2A
SCHEMBL24815007 0.86 DRD2 (0.41) TRPV4DRD2DRD4DRD3HTR2A
SCHEMBL19954603 0.83 TRPV4 (0.43) TRPV4DRD2DRD4DRD3ALDH1A1
SCHEMBL25745811 0.80 DRD2 (0.38) DRD2DRD4DRD3SIGMAR1
SCHEMBL24816270 0.80 DRD2 (0.38) TRPV4DRD2DRD4DRD3HTR2A
SCHEMBL24815012 0.80 DRD2 (0.40) DRD2DRD4DRD3TLR9TLR8
SCHEMBL25745825 0.79 DRD2 (0.39) DRD2DRD4DRD3TLR9TLR8
SCHEMBL18161165 0.78 DRD2 (0.43) DRD2DRD4DRD3ALDH1A1POLB
SCHEMBL19953968 0.78 KDM4E (0.39) DRD2DRD4DRD3ALDH1A1HPGD
SCHEMBL25745817 0.78 KDM4E (0.42) DRD2DRD4DRD3ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9914706-B2 N-substituted pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2018-03-13 US disclosed